These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 21704169)
1. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169 [TBL] [Abstract][Full Text] [Related]
2. Heterologous protein production and delivery systems for Lactococcus lactis. Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806 [TBL] [Abstract][Full Text] [Related]
3. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines]. Shi D; Song Y; Li YJ Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080 [TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272 [TBL] [Abstract][Full Text] [Related]
5. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
6. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Raha AR; Varma NR; Yusoff K; Ross E; Foo HL Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459 [TBL] [Abstract][Full Text] [Related]
7. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Wells J Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390 [TBL] [Abstract][Full Text] [Related]
8. A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression. Simões-Barbosa A; Abreu H; Silva Neto A; Gruss A; Langella P Appl Microbiol Biotechnol; 2004 Jul; 65(1):61-7. PubMed ID: 14758518 [TBL] [Abstract][Full Text] [Related]
9. Use of attenuated bacteria as delivery vectors for DNA vaccines. Daudel D; Weidinger G; Spreng S Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482 [TBL] [Abstract][Full Text] [Related]
10. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by Duarte SOD; Monteiro GA Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129 [TBL] [Abstract][Full Text] [Related]
11. Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix. Kim TW; Igimi S; Kajikawa A; Kim HY J Appl Microbiol; 2008 Jun; 104(6):1636-43. PubMed ID: 18298534 [TBL] [Abstract][Full Text] [Related]
12. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer. de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465 [TBL] [Abstract][Full Text] [Related]
14. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines. Mota RM; Moreira JL; Souza MR; Horta MF; Teixeira SM; Neumann E; Nicoli JR; Nunes AC BMC Biotechnol; 2006 Jan; 6():2. PubMed ID: 16396687 [TBL] [Abstract][Full Text] [Related]
15. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182 [TBL] [Abstract][Full Text] [Related]
16. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice. Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632 [TBL] [Abstract][Full Text] [Related]
17. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo. Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479 [TBL] [Abstract][Full Text] [Related]
18. Live bacterial delivery systems for development of mucosal vaccines. Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657 [TBL] [Abstract][Full Text] [Related]
19. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495 [TBL] [Abstract][Full Text] [Related]
20. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Villena J; Medina M; Raya R; Alvarez S Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]